Shenzhen Neptunus Pharmaceutical Research Institute

Shenzhen Neptunus Pharmaceutical Research Institute is the core research and development arm of the Neptunus Group, one of China's largest pharmaceutical conglomerates. The institute focuses on the discovery and development of innovative small molecule drugs, biologics, and high-end generic formulations across several therapeutic areas including oncology, cardiovascular health, and metabolic disorders. It operates advanced laboratories and pilot plants that support the entire drug development lifecycle from lead optimization to clinical trial management. By leveraging its parent company's extensive manufacturing and distribution network, the institute plays a critical role in bringing new therapeutic options to the Chinese and international markets.